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IntroductIon
“Collapse therapy” was extensively used during the 
first half of the previous century for the treatment 
of pulmonary tuberculosis. Artificial pneumothorax, 
thoracoplasty, one of the various available plombage 
techniques and phrenic nerve crash were the available 
techniques to collapse the diseased part of the lung1,2. 
All these techniques were abandoned since the devel-
opment of effective antituberculous chemotherapy in 
the mid-fifties2. Artificial pneumothorax was the com-
monest way to perform “collapse therapy” because of 
its simplicity, minimal invasiveness and better preser-
vation of overall pulmonary function3.
The late complications of collapse therapy for pul-
monary tuberculosis are well known from the past. 
Currently, these complications are rarely seen because 
these techniques were abandoned more than fifty 
years ago2,4,5. A recent case of pleural empyema with 
Escherichia Coli which has developed 59 years after 
the creation of artificial pneumothorax for the treat-
ment of pulmonary tuberculosis is presented. The pos-
sible mechanisms of residual pleural space infection 
and the therapeutic options of this rare clinical entity 
are discussed.
cASE PrESEntAtIon
A 79-year old man was urgently admitted in the De-
partment of Internal Medicine with clinical signs of 
systematic inflammatory response. He was recently 
treated with oral administration of ciprofloxacin for 
14 days for urinary infection with Escherichia Coli. 
Urinary infection was detected one month before, 
when the patient was examined in the outpatient de-
partment for complaints of malaise and weight loss. 
The patient had history of pulmonary tuberculosis that 
was successfully treated with artificial pneumothorax 
59 years ago. He had also history of prostate hyper-
trophy, arterial hypertension, coronary artery disease 
and acute myocardial infarction that occurred before 
14 years. He underwent surgery for myocardial revas-
cularization seven years ago. 
At admission the patient had low paO
2
 (57 mmHg), 
low oxygen saturation (87%) on breathing room air 
and hypercarbia (paCO
2 
= 55 mmHg), while arterial 
blood ph was normal (ph = 7.39). Hypoxemia was 
partially reversed with the administration of oxygen. 
The patient had also anaemia (Ht: 27%, Hb: 8.8g/dl, 
MCV: 65.5, MCH: 21.1), low serum ferrum levels 
(Fe = 15 mg/dl) and normal serum ferritin levels 
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(488ng/dl). White blood counts and serum levels of 
C-reactive protein and erythrocyte sendimentation 
rate were considerably elevated. Urine test and cul-
ture were negative. Mantoux test was negative and 
his electrocardiogram showed the presence of Q 
wave in II, III and AVF leads. Doppler echocardiog-
raphy revealed right ventricle dilatation, pulmonary 
hypertension (right ventricular systolic pressure: 60 
mmHg) and preservation of left ventricular function 
(EF = 50%). Spirometry results showed a severe re-
strictive pattern (FVC: 0.96L, FEV1: 0.75L, FEV1%: 
77%).
Plain chest radiography at admission demonstrated 
extensive opacity of the left hemithorax with deviation 
of the trachea to the left side and complete collapse of 
the left lower lobe. (Figure 1a) Chest computed to-
mography showed a fluid-filled residual pleural space 
enclosed within a calcified pleural envelop. (Figure 
1b) A small air-fluid level was observed within the 
loculated pleural effusion. (Figure 1b).
Thoaracentesis of the pleural effusion revealed 
purulent fluid. The Gram stain of pleural fluid has de-
tected the presence of a Gram negative microorgan-
ism which at culture was found to be Escherichia Coli. 
The patient received Timentin 5.2 g every 8 hours 
and chemoprophylaxis against tuberculosis with the 
twice-daily administration of tablets combining ri-
fampicin (300 mg) and isoniazid (150 mg). In addi-
tion, the patient underwent chest tube drainage of the 
loculated pleural collection. Chest tube drainage of the 
space was considered to be inadequate and the patient 
was finally submitted to open-window thoracostomy 
which was performed in the lowest portion of the 
pocket with partial resection of two ribs under local 
anaesthesia. The late manoeuvre resulted in complete 
drainage of the pleural space, complete subsidence of 
the infectious process and re-expansion of lung pa-
renchyma to a large degree. Cultures and polymerase 
chain reaction of the pleural fluid failed to detect the 
presence of Myobacterium and consequently antitu-
berculous chemotherapy was discontinued after three 
weeks. 
Because of the poor performance status of the pa-
tient, a permanent open-window thoracostomy was 
considered to be the appropriate solution for the in-
fected residual pleural space. The patient recovered 
well and he still remains in relatively good clinical 
condition three years later, while he recently under-
went operative repair of a large inguinal hernia under 
local anaesthesia.
Figure 1. a: Plain chest radiography at admission: Extensive opacification of the left hemithorax and deviation of the trachea 
to the left. 
b: Chest CT scan: Residual pleural space filled with fluid. Small-air fluid level on the top of the space and extensive 
calcification of the pleura.
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dIScuSSIon
Artificial pneumothorax for the treatment of tuber-
culosis was introduced in Italy during 1882 by Carlo 
Forlaini, while it became widely adopted in Europe 
and in the United States of America quite later, after 
19121. However, the first report belongs to James Car-
son from Liverpool who first had the idea to create 
an artificial pneumothorax for the treatment of pulmo-
nary tuberculosis in 18221. The “philosophy” of col-
lapse therapy was to produce compressive atelectasis 
of the diseased portion of the lung and to “encapsu-
late” the disease within the atelectatic lung. By put-
ting the diseased part of the lung at rest with “collapse 
therapy”, the healing process was promoted and the 
spread of the tuberculous material to the non-diseased 
parts of both lungs was avoided.1,2 Multiple adhesions 
between pleura and lung that could prevent the lung to 
effectively collapse were considered to be a contrain-
dication for “collapse therapy” until Jacobaeus has 
introduced thoracoscopy in 1910 for breaking-down 
these adhesions (pneumolysis), allowing that way the 
lung to effectively collapse6. Multi-drug resistant tu-
berculosis, intolerance of antituberculous drug treat-
ment because of toxicity and the high incidence of tu-
berculosis observed in the HIV patients could involve 
the renaissance of artificial pneumothorax as part of 
the modern treatment of tuberculosis in the above 
mentioned groups of patients3.
After the application of artificial pneumothorax for 
tuberculosis, the lung sometimes did not completely 
expand because of extensive fibrosis of lung parenchy-
ma and/or excessive pleural thickening and calcifica-
tion, as in the presented case5. A residual pleural space 
can be left behind because of partial re-expansion of 
the lung that is normally filled with fluid which by the 
progress of time is transformed to a fibrin gel. The re-
sidual space usually remains stable in size and sterile 
for life-long. Occasionally, an increase in the size of 
the residual pleural space that appears radiographical-
ly as an extensive opacification of the hemithorax can 
be observed, even several decades later. The phenom-
enon of progressive swelling of the residual pocket 
is called the “exudative process”5. Late tuberculous 
empyema is rarely the cause of “exudative process”. 
Most common causes for the development of this pro-
cess are bronchial and esophageal fistulas which lead 
to infection of the space or the development of pleural 
lymphoma7-9.
A point that needs special attention in the present-
ed case is that infection of the residual pleural space 
with Escherichia Coli was associated with a recent 
urinary infection with the same micro-organism. The 
empyema could be attributed to a small bronchopleu-
ral fistula as suggested by the small air-fluid level 
seen within the pocket on CT scan done at admission. 
Hematogenic spread of the urinary infection within 
the residual pleural cavity could be another, unusual 
cause of empyema formation. Whatever the mecha-
nism of residual pleural space infection, it represents 
a serious and life-threatening complication for the old, 
debilitated and suffering from serious comorbidities 
patient who underwent artificial pneumothorax for the 
treatment of his pulmonary tuberculosis several de-
cades ago. 
The treatment options of late infection of the re-
sidual pleural space after artificial pneumothorax 
are thoracotomy and decortication of the lung (with 
or without the addition of thoracoplasty that mainly 
depends on the post-decortication expansion of the 
lung parenchyma), extrapleural pneumonectomy 
in case of totally destroyed lung and open window 
thoracostomy7,8. The later way is the preferable option 
to drain the heavily calcified, infected pleural space in 
the high-risk for major intervention, old patient with 
serious comorbidities; it offers eradication of the in-
fection without operative risk, while by the progress 
of time, the daily care of permanent thoracostomy 
window becomes very easy and the patient is able for 
self-care. 
In conclusion, late infection of the residual pleural 
space should be kept in mind when patients who un-
derwent artificial pneumothorax for the treatment of 
pulmonary tuberculosis many years before deteriorate 
and their plain chest radiography shows considerable 
changes, with the form of extensive opacification of 
the hemithorax or swelling of a stable for many years 
pleural pocket. Infection of the residual pleural space 
can be successfully treated by the creation of a per-
manent open-window thoracostomy that can be easily 
performed under local anaesthesia and without sig-
nificant operative risk. 
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ΠΕΡΙΛΗΨΗ: Ένας άνδρας 79 ετών με επιβαρυμένο ιατρικό ιστορικό, εμφάνισε εμπύημα σε υπολειμματική υπεζωκοτική 
κοιλότητα, η οποία αποτελούσε κατάλοιπο «τεχνητού» πνευμοθώρακα που είχε γίνει πριν από 59 χρόνια για τη θεραπεία 
πνευμονικής φυματίωσης. Η παροχέτευση της κοιλότητας με ανοιχτή θωρακοστομία είχε σαν αποτέλεσμα την αναστροφή 
της τοξικής κατάστασης και γρήγορη ανάρρωση.
Λέξεις Κλειδιά: Πνευμονική φυματίωση, Θεραπεία σύμπτωσης του πνεύμονα, Τεχνητός πνευμοθώρακας, Απώτερες επιπλοκές 
της θεραπείας σύμπτωσης του πνεύμονα, Εμπύημα θώρακα.
Φλεγμονή της υπολλειμματικής υπεζωκοτικής κοιλότητας 59 χρόνια  
μετά τη δημιουργία “τεχνητού” πνευμοθώρακα για πνευμονική φυματίωση.
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